Evoke Pharma Ownership | Who Owns Evoke Pharma?
Evoke Pharma Ownership Summary
Evoke Pharma is owned by 6.09% institutional investors, and 93.91% retail investors. Fidelity Extended Market Index is the top mutual fund, with 0.55% of its assets in Evoke Pharma shares.
EVOK Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Evoke Pharma | 6.09% | - | 93.91% |
| Sector | Healthcare Stocks | 57.39% | 9.93% | 32.68% |
| Industry | Specialty & Generic Drug Manufacturers Stocks | 26.69% | 10.91% | 62.39% |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 31, 2022 | 18 | -21.74% | 1,997,549 | -2.46% | 6 | 15.05% | 7 | -12.50% | 5 | - |
| Dec 31, 2021 | 23 | 4.55% | 2,047,919 | -51.29% | 6 | 3.81% | 8 | - | 5 | - |
| Sep 30, 2021 | 22 | - | 4,204,343 | -6.66% | 12 | 6.68% | 8 | -20.00% | 5 | 66.67% |
| Jun 30, 2021 | 22 | -24.14% | 4,504,481 | 4.81% | 13 | 7.31% | 10 | -16.67% | 3 | -25.00% |
| Mar 31, 2021 | 29 | -9.38% | 4,297,637 | 66.20% | 13 | 13.41% | 12 | -20.00% | 4 | -33.33% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Fidelity Extended Market Index | 8.15K | 0.55% | -52.00 |
| Vanguard Institutional Extnd Mkt Idx Tr | 2.49K | 0.17% | - |
| Fidelity Series Total Market Index | 1.22K | 0.08% | 502.00 |
| State Street Balanced Index K | 314.00 | 0.04% | - |
| Fidelity Nasdaq Composite Index | 373.00 | 0.03% | - |
| Spartan Extended Market Index Pool F | 176.00 | 0.01% | 52.00 |
| Spartan Extended Market Index Pool E | 176.00 | 0.01% | 52.00 |
| Northern Trust Extended Eq Market Idx | 168.00 | 0.01% | - |
| NT Ext Equity Mkt Idx Fd - L | 168.00 | 0.01% | - |
| NT Ext Equity Mkt Idx Fd - NL | 101.00 | 0.01% | - |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2029 Q1 | - | - |
| 2025 Q1 | - | 1 |
| 2024 Q4 | - | - |
| 2024 Q3 | - | - |
| 2024 Q2 | - | - |
EVOK Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools